What we're reading, January 13, 2017: more states consider contraception laws with Affordable Care Act (ACA) in peril; GOP will speed up timeline to replace ACA; Tom Price will sell his stocks to avoid conflicts.
When the Affordable Care Act (ACA) is repealed by Republicans in Congress, millions of women will lose access to free birth control. According to Reuters, an increasing number of states are looking to join the ranks of California, Maryland, Vermont, and Illinois, which added the ACA’s contraception mandate into state law. Democrats in Colorado, Massachusetts, Minnesota, and New York are considering similar measures since President Barack Obama’s healthcare law, and the contraception mandate, are in peril.
Meanwhile, the repeal of the ACA is undergoing some timeline changes. Initially, GOP leadership were considering repealing the law immediately, but delaying the effects for 2 or 3 years while a replacement was hammered out. After the president-elect said he wanted repeal and replace to take place almost simultaneously, Republicans in Congress have changed their tune, reported The Wall Street Journal. House Speaker Paul Ryan, R-Wisconsin, is now saying that the House will have replacement legislation alongside the repeal. With no replacement legislation yet announced, Republicans will have a tight deadline to meet.
After calls for an ethics investigation from some Democrats that Representative Tom Price, R-Georgia, the president-elect’s pick to run HHS, will sell of his stock holdings. Price currently holds stock in more than 40 companies, but he will divest himself of that stock if the Senate confirms him, according to The New York Times. Democrats had raised concerns that Price may have add access to insider information. In addition, Price will resign from his position with the American Medical Association.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Study Validates Smartphone Analysis for Predicting Obstructive Sleep Apnea
November 29th 2023Findings show breathing sounds recorded by smartphones during sleep at home can reliably identify obstructive sleep apnea, presenting an innovative and accessible alternative to traditional in-laboratory polysomnography.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen